Professional labeling.
21 C.F.R. § 333.280
in effectEffective: 2024-07-01The labeling provided to health professionals (but not to the general public) may contain the following additional indication:
(a) For products containing haloprogin or miconazole nitrate identified in § 333.210 (a) and (c). “For the treatment of superficial skin infections caused by yeast (Candida albicans).”
(b) [Reserved]
Source: eCFRURL: https://www.ecfr.gov/api/versioner/v1/full/2024-07-01/title-21.xmlFetched: 7/26/2026
